Taiwan News18 天
iBio Discovers Novel Antibody Targeting Activin E in Collaboration with AstralBio
Human genetics provide strong evidence for Activin E as a therapeutic target. Individuals with a protective loss-of-function (pLOF) mutation in the INHBE gene have a healthier cardiometabolic profile, ...
Yahoo Finance19 天
iBio Discovers Novel Antibody Targeting Activin E in Collaboration with AstralBio
Individuals with a protective loss-of-function (pLOF) mutation in the INHBE gene have a healthier cardiometabolic profile, including less abdominal fat, lower triglycerides, and lower risk of type ...
Nasdaq18 天
iBio, Inc. and AstralBio Collaborate to Develop First Antibody Targeting Activin E for ...
Individuals with a protective loss-of-function (pLOF) mutation in the INHBE gene have a healthier cardiometabolic profile, including less abdominal fat, lower triglycerides, and lower risk of type ...
Finanznachrichten18 天
iBio, Inc.: iBio Discovers Novel Antibody Targeting Activin E in Collaboration with AstralBio
Individuals with a protective loss-of-function (pLOF) mutation in the INHBE gene have a healthier cardiometabolic profile, including less abdominal fat, lower triglycerides, and lower risk of type ...